Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Current Assets (Including Current Investments) ₹1,609 Cr₹3,877 Cr₹3,593 Cr₹3,159 Cr₹2,678 Cr

What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹1,609 Cr based on Mar2024 Consolidated results.
Year Net Current Assets
Mar2024₹1,609 Cr
Mar2023₹3,877 Cr
Mar2022₹3,593 Cr
Mar2021₹3,159 Cr
Mar2020₹2,678 Cr

How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2024 ₹1,609 Cr
-58.49
Mar2023 ₹3,877 Cr
7.92
Mar2022 ₹3,593 Cr
13.75
Mar2021 ₹3,159 Cr
17.96
Mar2020 ₹2,678 Cr -

Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses